Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pil Soo Sung

Showing results (11-20 of 158) with videos related to

Pageof 16
Sort By:
Diagnostics (Basel, Switzerland)|February 24, 2024
The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver DiseaseJaejun Lee, Seungmyeon Choi, Seong-Hyun Cho, et al.
Plos One|December 2, 2021
Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinomaJi Won Han, Pil Soo Sung, Jeong Won Jang, et al.
Gut and Liver|December 6, 2024
Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young AdultsJaejun Lee, Chang In Han, Dong Yeup Lee, et al.
Frontiers in Oncology|August 6, 2020
Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic OptionHyun Yang, Pil Soo Sung, Eun Sun Jung, et al.
Viruses|July 2, 2020
microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and de novo LipogenesisEun Byul Lee, Pil Soo Sung, Jung-Hee Kim, et al.
Nature Communications|February 13, 2016
Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5ANari Kim, Min-Jung Kim, Pil Soo Sung, et al.
Frontiers in Oncology|November 17, 2022
Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to goPil Soo Sung, Isaac Kise Lee, Pu Reun Roh, et al.
European Radiology|March 29, 2022
Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinomaSeo Yeon Youn, Bohyun Kim, Dong Hwan Kim, et al.
Hepatology International|October 11, 2024
Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal studyJaejun Lee, Jinson So, Chang In Han, et al.
Annals of Laboratory Medicine|October 16, 2020
Targeted Next-Generation Sequencing of Plasma Cell-Free DNA in Korean Patients with Hepatocellular CarcinomaHyojin Chae, Pil Soo Sung, Hayoung Choi, et al.
Pageof 16

Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Diagnostics (Basel, Switzerland)|February 24, 2024
The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver DiseaseJaejun Lee, Seungmyeon Choi, Seong-Hyun Cho, et al.
Plos One|December 2, 2021
Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinomaJi Won Han, Pil Soo Sung, Jeong Won Jang, et al.
Gut and Liver|December 6, 2024
Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young AdultsJaejun Lee, Chang In Han, Dong Yeup Lee, et al.
Frontiers in Oncology|August 6, 2020
Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic OptionHyun Yang, Pil Soo Sung, Eun Sun Jung, et al.
Viruses|July 2, 2020
microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and de novo LipogenesisEun Byul Lee, Pil Soo Sung, Jung-Hee Kim, et al.
Nature Communications|February 13, 2016
Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5ANari Kim, Min-Jung Kim, Pil Soo Sung, et al.
Frontiers in Oncology|November 17, 2022
Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to goPil Soo Sung, Isaac Kise Lee, Pu Reun Roh, et al.
European Radiology|March 29, 2022
Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinomaSeo Yeon Youn, Bohyun Kim, Dong Hwan Kim, et al.
Hepatology International|October 11, 2024
Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal studyJaejun Lee, Jinson So, Chang In Han, et al.
Annals of Laboratory Medicine|October 16, 2020
Targeted Next-Generation Sequencing of Plasma Cell-Free DNA in Korean Patients with Hepatocellular CarcinomaHyojin Chae, Pil Soo Sung, Hayoung Choi, et al.
Pageof 16